Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI coach for lung surgery recovery: could it cut complications?

NCT ID NCT07588737

Symptom relief Sponsor: The First Affiliated Hospital of Guangzhou Medical University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether an artificial intelligence (AI) system can improve recovery after lung cancer surgery. About 868 patients from 20 hospitals will be randomly assigned to either standard care or standard care plus an AI tool that tracks symptoms, activity, and recovery progress. The AI provides personalized advice and alerts the care team if problems arise. The main goal is to see if the AI reduces the number of days patients experience severe symptoms like pain, fatigue, and shortness of breath within the first month after surgery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
multimodal artificial intelligence system
What this could lead to
If it works, this could provide a better way to monitor and manage symptoms after lung cancer surgery, potentially speeding up recovery and reducing complications.
What could go wrong
This is a relatively early-stage trial testing a new AI approach, so it may not prove better than standard care. The system relies on patient-reported data, which can be incomplete or inaccurate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 868 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2025

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age 18 years or older. 2. Clinically or pathologically diagnosed with lung cancer. 3. Undergoing lung cancer-related thoracic surgery. 4. Surgical procedures may include video-assisted thoracoscopic surgery, robot-assisted thoracic surgery, or open thoracic surgery. 5. Surgical extent may include wedge resection, segmentectomy, lobectomy, sleeve resection, combined resection, bilobectomy, or pneumonectomy. 6. Clinically stable after surgery and able to participate in symptom assessment and postoperative recovery management. 7. Able to use a smartphone or study device, or has a caregiver who can assist with use. 8. Able to complete patient-reported symptom assessments and postoperative recovery information reporting. 9. Provides written informed consent. Exclusion Criteria: 1. Patients receiving non-surgical treatment only. 2. Patients undergoing bronchoscopy, percutaneous biopsy, or other non-surgical diagnostic or therapeutic procedures only. 3. Clinically unstable after surgery and unable to participate in symptom assessment or recovery management. 4. Requiring prolonged intensive care unit treatment, continuous advanced life support, or continuous intensive medical management. 5. Severe cognitive impairment, psychiatric disorder, language communication disorder, or other conditions that preclude completion of study assessments. 6. Unable to use a smartphone or study device and without a caregiver who can assist with use. 7. Currently participating in another interventional clinical study that may affect the primary outcome of this trial. 8. Any other condition judged by the investigator to make the patient unsuitable for participation in this study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Artificial intelligence (AL) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

lung cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Artificial intelligence (AL) Postoperative care Randomized controlled trial (RCT) Rehabilitation

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • the First Affiliated Hospital of Guangzhou Medical University, Guangzhou,Guangdong 510120

    RECRUITING

    Guangzhou, Guangdong, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.